logo
Fighting for funds: A new era of HIV activism

Fighting for funds: A new era of HIV activism

Mail & Guardian22-04-2025

The Health and Human Rights Oral History Project's video testimonies that capture three decades of health activism from around the world, might provide a blueprint for the next wave of HIV activism. (Bhekisisa)
'So the US funding cuts happened and I was looking for the noise! I was asking the other day, 'Where are my people, why aren't they shouting?'' says Sisonke Msimang, a South African writer and political scientist.
Msimang was a vocal critic of the Aids denialism of the Mbeki era, supporting the health advocacy organisation Treatment Action Campaign (TAC) in what became a
She is also one of 29 health rights activists featured in the
[WATCH] LAUNCH OF THE ORAL HISTORY PROJECT
In South Africa, more than half of HIV and TB projects funded by the US government's Aids fund, Pepfar,
The health department commissioned a modelling study from Wits University's
The preprint of the study's results will be published this week.
'We need to see urgency from the government to reverse this. We're not seeing that,' warns Sasha Stevenson, who heads up the social justice organisation Section27.
The cost to contain those numbers? R2.82 billion.
Activists say getting the government to find the money might require a back-to-basics approach to HIV advocacy.
'I was thinking it's time for noise again,' says Msimang, who now lives in Perth, Australia. 'We must meet this moment, pushing for full funding of health by our own government.'
Looking back to move forward
The series of video testimonies that capture three decades of health activism from around the world might provide a blueprint for the next wave of activism.
The interviews are housed by the
'We saw that the projects represented so much that needed to be preserved, to be able to learn from and to be inspired,'
Jonathan Cohen, director of policy engagement at the Global Health Institute, told
Bhekisisa
.
Activism in South Africa takes prominent space in the archive, with testimonies from
Grants can be ended, speakers at the oral history project's
Making history
Stevenson said the archive gives unique insights into the back stories of the many layers of activism that eventually bring about change.
In the 'essential medicines' case in the late 1990s and early 2000s, public protests drew attention to the need for HIV treatment around the world. In South Africa, those protests took on the form of scientists, activists, lawyers and the news media coming together
That activism resulted in
Twenty years later, the Life Esidimeni
It was largely due to the activism of organisations such as Section27 and the
In her
But only if journalists, activists and researchers tap into it. That point, says Noor Nieftagodien, head of the history workshop at Wits University, is 'amplified by the current circumstances of Trumpism, where … there is an urgent need for more of this kind of human rights activism'.
The universal lesson from the archive, he says, is that results come from organising and mobilising people around a cause.
Holding the state accountable
'In 20 years, we'll look back to what happened in 2025 and people will want to know a fuller story about how people responded,' says Fatima Hassan, the founder and director of the
She says the oral histories give courage, but in some ways activism today is more complicated.
In South Africa, activists now have to deal with a government of national unity (GNU), instead of a single party with one ideology. The unity government is fragile, and Hassan says the Health Justice Initiative and other civil society organisations
So far, the health department says it has commissioned the modelling study previously mentioned, and
The department's deputy director general for the country's National Health Insurance scheme, who led the calculations, told
Bhekisisa
the department is in the process of applying for emergency funding from the treasury, via section 16 of the Public Finance Management Act, on 15 April.
But Hassan says the slow pace at which the department has been moving to get to this point is frustrating.
She says the business community should also have stepped forward by now to acknowledge the scale of the crisis. 'History will judge those with money and resources that didn't come forward and say they're trying to mitigate the impact.'
But, she argues, some of the 'noise' of activism was initially stifled; people speaking for organisations affected by cuts wouldn't go public — or did so anonymously — so as not to poke the bear (US President Donald Trump) and lose their contract.
Other things have changed, too.
Mark Heywood, a founding member of the TAC, now serving on its board, says activism is debased because activists get sucked into policy processes.
For example, he says, the
For Cohen, the close working relationship between activists and government in South Africa is a sign of activist success — it usually means that governments have started fulfilling their health obligations and need civil society to help them.
Back to basics?
The funding crisis is a reminder that the need to hold the state accountable never ends, activists say.
Msimang says working with the state is both essential and seductive. 'Where activists find themselves now is [that] we became friends with government, helping to expand the capacity of the state to reach out to communities.'
She says the shutdown of the US Agency for International Development, USAid, through which
Mluleki Zazini, the director of the
'I think we need to go back to the streets so that we can voice our needs,' says Zazini, who also chairs the civil society forum within Sanac. 'We criticise them in boardrooms … maybe they've forgotten that we used to mobilise people to get action.'
Bhekisisa
's Mia Malan was the moderator for the online
This story was produced by the
. Sign up for the
.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New healthcare service launched for taxi drivers in Orange Farm
New healthcare service launched for taxi drivers in Orange Farm

IOL News

time7 hours ago

  • IOL News

New healthcare service launched for taxi drivers in Orange Farm

Ribbon cutting at the Mpathy Clinic opening in Orange Farm Image: Supplied This Men's Health Month, the question of who looks after those who drive the heart of South Africa's transport system has been strikingly addressed. In a collaborative effort, Rhiza Babuyile, a prominent non-profit organisation, has teamed up with the Department of Health, Johannesburg Health District Services, and the Orange Farm United Taxi Association (OFUTA) to launch a much-needed healthcare initiative specifically for taxi drivers. The Mpathy Clinic officially opened its doors at one of Orange Farm's busiest taxi ranks, signalling a valuable addition to the community that prioritises the health needs of one of the most hardworking groups in South Africa. 'Taxi drivers avoid going to a clinic because their working conditions simply don't allow them the time to wait in long queues. With this new service, they'll get treatment fast. Quick in and out, no long lines. It's a quality service, built around their reality,' stated Lerato Seheri, Healthcare Manager at Rhiza Holdings. The convenience of the newly launched clinic is a game changer for taxi drivers, who often work long hours under pressure. According to Seheri, the clinic is tailored specifically to accommodate their busy schedules, with consultation fees ranging between R100 and R300, a substantial saving compared to private healthcare costs. 'This clinic meets them where they are and provides them with care without disrupting their day,' she added. The newly launched Mpathy Clinic in Orange Farm Image: Supplied The initiative aligns with South Africa's national 'Closing the Gap' ART Campaign, which aims to identify and support the 1.1 million individuals living with HIV who know their status but have not yet accessed treatment. Seheri highlighted this as critical, remarking, 'Men are significantly less likely than women to engage with routine health services, often leading to late diagnoses of health conditions that could have been manageable or preventable.' Mmakobo Gaegake, Programme Manager for HIV, AIDS, Sexually Transmitted Infections, and Tuberculosis (HAST), echoed these sentiments, underscoring the significance of providing health services at the taxi rank.

Motsoaledi's big HIV treatment jump: Is it true?
Motsoaledi's big HIV treatment jump: Is it true?

Mail & Guardian

time8 hours ago

  • Mail & Guardian

Motsoaledi's big HIV treatment jump: Is it true?

How close is South Africa to meeting its HIV treatment goals? We look at the numbers. (NIAID/Wikimedia) Numbers are powerful. They can also be dangerous if not used correctly. When the The health department's goal is In his words, the department has reached 'more than 50% of the target' they set out to achieve by the end of the year. If that gap is closed, South Africa would have met two of the three But knowing exactly how much the gap is closing is tricky, because people who know they have HIV may start and stop and then restart treatment again later — sometimes several times — during the course of their care. So, many of the 520 700 previously diagnosed people Motsoaledi says are now on medication could, at least in theory, very well be people who are counted repeatedly as they cycle in and out of treatment. But because the patient information system isn't digitally centralised — most clinics still keep track of their clients on paper, which means different facilities can't easily access one another's records — someone who stops treatment at one clinic can easily be counted as a new start at another, rather than a restart. The set of UN targets aim for 95% of people in a country with HIV to know their diagnosis, 95% of those being on treatment and 95% of those taking medication having such low levels of virus in their bodies that they can't infect someone through sex. 'The reason that we [were] able to reach half a million within a short space of time, was because of weekly check-in meetings with provinces, where reports that come from the ground are verified in the presence of all provincial colleagues before they are regarded as final figures for reporting,' said the minister. But simply counting better isn't the same as doing better, and critics called the reported progress Why? Because for the past few years, the number of people with HIV who have gone on treatment has Moreover, that was while treatment programmes had funding and US-backed money for HIV projects was in place. So now, at a time of We dive into the data to get a sense of what the numbers really mean. Mind the gap In 2021, South Africa was about 1.2-million people short of its 95%-treatment goal; by 2025 the shortfall will likely be 990 000. That means that the gap — that is, the difference between where the country actually is and where it wants to be when it comes to HIV treatment — has closed by about 210 000. So there's been progress, but it's been slow: in total, only about 700 000 more people are on HIV medication today than five years ago. 'Getting that last one million or so people on treatment is not simple,' says Kate Rees, public health specialist at the Sometimes people miss an appointment to get a refill of their medicine because they can't afford to take time off work to go to the clinic or they might have moved to another province or district and so they don't go back to the facility where they first got their prescription, she explains. The longer the interruption lasts, the more hesitant people are to go back, says Rees, because they dread Says Rees: 'The health service expects people to be very rigid with their appointments, but life just is not like that.' Slow progress To get a sense of the progress towards meeting the UN's second target in its 95-95-95 cascade, it's best to look at the difference in the total number of people on HIV treatment from year to year, says Leigh Johnson, one of the lead developers of the Although the number of people on medication is increasing, the number grows less and less each year. For example, in 2020, about 291 000 more people were on treatment than in 2019. By 2021, though, the number had grown only by about 225 000. Current forecasts from the model are that the total number of people on treatment will grow by only about 160 000 this year. But that's based on programmes running like they have up to now — and with recent upsets because of US funding cuts, it may be an unreasonable assumption, Johnson says. Part of the reason for the small net gain every year, is that although many people sign up for medication in a year, many also stop coming back to get their scripts refilled. Of those who drop out of treatment, some might choose to restart within a couple of months again, while others may pause their treatment for more than a year. In 2023, for example, roughly 793 500 people who had been on treatment before weren't any longer, but about 728 000 who received medication were restarters, Thembisa numbers show. So even though some people who stop taking their medication might not restart — or restart quickly — the total number who are on treatment still grows; it's just slow-going. This means getting a handle on how close to — or far from — the 95%-treatment mark South Africa is, is more dynamic than simple addition. Stops, starts and restarts 'There will always be people who interrupt their treatment,' says Rees. 'It's not possible to keep everyone perfectly in the system all the time — that's life.' But what's important, she says, is to make those pauses as short as possible by helping people to get back on medication quickly and easily — without judgment. Gesine Meyer-Rath agrees. She's a health economist at Data in the Thembisa model shows that over the years, the number of people starting medication for the first time — in other words, those who have never been on treatment before — has shrunk, but at the same time counts of restarters have grown. Her group's analyses have shown that honing in on keeping people on HIV treatment is the best way to go — But to plan sensibly, she explains, policymakers should know how many people are first-time starters, how many pause treatment but then restart, and how many stop and don't come back at all. 'The more detail programme planners have in the data, the better,' she says. 'The [government's] This is exactly where things can become tricky in future if the holes left by the US funding cuts aren't plugged. Because of the US's aid withdrawal, about 40% of South Africa's HIV data capturers will likely have lost their jobs by September, Says Meyer-Rath: 'The less data we have, the more we're flying blind, which leaves space for bickering over the data that is still there.' This story was produced by the . Sign up for the .

Bugs sent into battle — meet the SA team using insects instead of pesticides to tackle invasive plants
Bugs sent into battle — meet the SA team using insects instead of pesticides to tackle invasive plants

Daily Maverick

time10 hours ago

  • Daily Maverick

Bugs sent into battle — meet the SA team using insects instead of pesticides to tackle invasive plants

Sustenance farmers are hit the hardest by the impacts of invasive plant species. Scientists are working to change that, but they face challenges. South African farmers spend about R1,200 per hectare on weed control, including herbicide application and other methods, according to an estimation from 2021. Their costs also include diesel for machinery, crop insurance and harvesting. Although commercial farmers feel the costs, they often have resources to buy pesticides, herbicides and manual labour to ensure their crops do well and the land is workable. Daily Maverick visited sustenance farmers in northern KwaZulu-Natal who were losing thousands of their goats to an illness they claim is from an invasive plant species – parthenium. In KwaNongoma, the weed is visible throughout the grazing land, and it is highly competitive with grass. It also causes rashes in children after long-term exposure, along with other effects. Daily Maverick visited the Plant Health and Protection unit of the Agricultural Research Council (ARC-PHP) in Hilton, Pietermaritzburg, where scientists focus on ecologically sound management strategies for agricultural pests, plant diseases and invasive plants. One of the researchers, Lorraine Strathie, said invasive plant species can be controlled by bringing insects from their country of origin to feed on them here. But if this sounds simple, it is not. The process takes devotion, trial and error and collaboration. 'For example, parthenium is indigenous to the lands around the Gulf of Mexico in North America. So in its native range, in their native range, plants have evolved for millions of years, and they have natural enemies in the form of insects which feed on them, fungi and other pathogens. So it's what we call top-down control,' she said. 'So, they reduce their reproductive output, the number of seeds they produce, and their growth rates. And these insects, many of these natural enemies, because the plants produce defensive chemicals, most of the insects and fungi that feed on them have become highly specialised to get around those chemicals and other defences. So they become highly, what we call host-specific – they only feed on one species of plant.' Entomologists and those in related sciences dedicate years to understanding which control agents are likely to be suitable to bring to South Africa. When the insects get here they are quarantined and numerous tests and observations are done to make sure they don't have a taste for South African plants, which would add them to a long list of pests instead of control agents. 'So one of the main theories is that when a plant is taken out of its native environment and brought to another continent, the natural enemies don't come with it because it comes as a seed, and then it can grow without any kind of top-down control. And its growth rates increase, its seed output increases, and it outcompetes the local plants. Then it becomes invasive,' Strathie said. The ARC-PHP was established in 1962 with the amalgamation of the divisions of eEntomology and plant pathology of the Department of Agriculture, Forestry and Fisheries. Challenges The challenge with this science is that it can take time and needs the land these agents have been placed on to not be disturbed by pesticides, herbicides and building. This requires land owners to cooperate with the team so they can check the population they have released every year to see how much it has grown, how far it has spread and the impact. To achieve optimal biological control, studies have shown that 'integrating various biological control options that include classical biological control, mycoherbicides and suppressive plants with management tools such as chemical, physical, grazing management and cultural management is desirable'. Dr Costas Zachariades, officer-in-charge and senior researcher in the ARC-PHP, explained that the population starts breeding by itself and feeds on the plant, and spreads by itself. 'So once we've got past that stage of what we call establishing the population, then it becomes self-sustaining, and it doesn't need any more human intervention. And so with weed control you have to keep on spraying with herbicide, uprooting manually, doing what you're doing. So there's always human intervention required on an ongoing basis, whereas with weed biocontrol, that is not needed. So it's a long-term, sustainable solution. The downsides are that it takes a long time,' Zachariades said. It could take up to 20 years for the biocontrol agent to reach its full potential – that is, being widespread over large areas, the plant has decreased and invasive plant growth is naturally stifled. But it could be effective in three to five years, according to the scientists. Community resistance Affected people, such as those in agricultural communities with small-scale farmers, have been resistant to the idea, worried that the agents will start eating their crops once the weeds are gone. Strathie emphasised that this is the core of their work in the quarantine lab, over and above growing the insect population – they do a number of tests to ensure the agent only eats that weed and nothing else. 'It's a very common perception. A lot of growers will know that some insects or pathogens can be highly host-specific,' she said. Even in the case of lantana, which had many different hybrids and varieties, some of the insects were so specific that they might only go for a certain colour of a certain hybrid. The agents could have certain chemical cues they required for attraction to a plant, as well as for mating and feeding. 'So the natural enemies we're using are really host-specific.' In the lab the team showed how the insects are not only plant-specific but eat specific parts of the plant – some eat the stem, some like the leaves, some lay eggs on the flowers, thereby crippling the invasive plant's growth. '… we ensure that whatever is released into the environment is completely safe. I mean, the science of weed biocontrol has been around for 112 years in South Africa, and South Africa is one of the leading countries in the world in this science. So it's quite a small community of weed biocontrol researchers in the country, but the science is very rigorous, we're not going to be introducing something that's going to be potentially harmful on other plants,' Strathie added. Funding This work appears to be significant in ensuring biodiversity, especially as civil society organisations are calling for the banning of a number of pesticides. And this team considers itself lucky because it receives funding from the Department of Agriculture, while other teams doing similar work have stopped due to a lack of funding. 'Funding, I think, globally is challenging, and invasive species often are not recognised for the level of importance of how they impact on people's livelihoods, not only from conservation, but food production and health,' Strathie said 'And I think there's generally not a common understanding of what kind of impact they may have. And I think [that] for research it's critical, and especially this type of research needs sustained funding for long periods, and once you have a biological control agent to be able to reap the benefits of all that investment. Developing a biocontrol agent, you then need government's national support to ensure it's rolled out to its full benefit.' Mass rearing for impact The team explained that a mass release of the tried-and-tested control agents has made an impact in biocontrol in affected provinces such as Mpumalanga and KwaZulu-Natal. This is made possible by the Department of Agriculture, which has been supporting the programme since 2023. 'But also previously, the Department of Forestry, Fisheries and the Environment (DFFE) were the major funders for biological control of weeds in South Africa. So there was a lot of R&D done in those decades with DFFE that we now also benefit from South Africa being able to [mass-rear] those agents,' Strathie said. Zachariades added that they have six major weeds currently, for which they have multiple biocontrol agents being mass reared at the unit and at Brunner Plot in Pretoria, a sister institute. Which meant that, if there were no more funding to mass-rear the agents, 'we can hasten their impact by releasing more of them and more often at many sites'. 'So, for example, for parthenium insect agents, we've got three of them, and we've got something like 400 release points already, and those will just keep increasing in KZN and Mpumalanga, because those are where the weed is most prevalent at the moment. It's in other provinces as well, but those are where it's really severely invading.' The team had also mass-reared agents for commelina, lantana pompom weed ('which is problematic on the high field at this stage') and Tecoma stans, or yellow bells ('it's become a big weed along the coast here') as well as the Mexican sunflower, all of which pose a threat to indigenous flora. DM

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store